-
A new dawn for chronic kidney disease – SGLT-2 inhibition as a novel strategy
A new dawn for chronic kidney disease – SGLT-2 inhibition as a novel strategy
Speaker: Hermann Haller, M.D., President, MDI Biological Laboratory About the Speaker: Hermann Haller, M.D. an international leader in kidney disease, hypertension and kidney and blood vessel regeneration, was appointed president […]
Free